Endothelin antagonists in salt-dependent hypertension associated with renal insufficiency

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 5, 1996, Pages 643-651

  Doucet, Jean ^a,b   Gonzalez, Walter ^b   Michel, Jean Baptiste ^b  

^a INSERM   (France)

^b UNIVERSITÉ DE ROUEN   (France)

Author keywords

Dahl salt sensitive rats; DOCA salt rats; Endothelin antagonists; Hypertension; Renal insufficiency

Indexed keywords

4 AMINOHIPPURIC ACID; BOSENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DEOXYCORTICOSTERONE ACETATE; ENDOTHELIN A RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; HIPPURIC ACID; INULIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIURESIS; GLOMERULUS FILTRATION RATE; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY FAILURE; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD PRESSURE; DESOXYCORTICOSTERONE; ENDOTHELINS; GLOMERULAR FILTRATION RATE; HYPERTENSION; KIDNEY FAILURE; PEPTIDES, CYCLIC; RATS; RATS, WISTAR; RENAL CIRCULATION; SODIUM CHLORIDE; SULFONAMIDES;

EID: 0029989255     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199605000-00005     Document Type: Article

References (27)

1. Kon V, Badr KF. Biological actions and pathophysiologic significance of endothelin in the kidney. Kidney Int 1991;40:1-12.
2. Kohan DE, Hughes AK, Perkins SL. Characterization of endothelin receptors in the inner medullary collecting duct of the rat. J Biol Chem 1992;267:12336-40.
3. Bigaud M, Pelton JT. Discrimination between ET-A and ET-B-receptor-mediated effects of endothelin-1 and (Ala 1,3.11,15)endothelin-1 by BQ-123 in the anaesthetized rat. Br J Pharmacol 1992;107:912-8.
4. Takemoto F, Uchida S, Ogata E, Kurukawa K. Endothelin-1 and endothelin-3 binding to rat nephrons. Am J Physiol 1993;265: F827-32.
5. Terada Y, Tomita K, Nonoguchi H, Marumo F. Different localization of two types of endothelin receptor mRNA in microdissected rat nephron segments using reverse transcription and polymerase chain reaction essay. J Clin Invest 1992;90:107-12.
6. Takayanagi R, Hashiguchi T, Ohashi M, Nawata H. Regional distribution of endothelin receptor in porcine cardiovascular tissues. Regul Peptide 1990;27:247-55.
7. Pernow J, Boulier JF, Franco-Cerecera A, Lacroix JS, Matran R, Lundberg JM. Potent selective vasoconstrictor effects of endothelin in the pig kidney in vivo. Acta Physiol Scand 1988;134:573-4.
8. Clozel M, Fischli W, Guilly C. Specific binding of endothelin on human vascular smooth muscle cells in culture. J Clin Invest 1989; 83:1758-61.
9. Ihara M, Noguchi K, Saeki T, et al. Biological profiles of highly potent novel endothelin antagonists selective for the ET-A receptor. Life Sci 1992;50:247-55.
10. Clozel M, Breu V, Gray GA, et al. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther 1994;270:228-35.
11. Ihara M, Saeki T, Fukuroda T, et al. A novel radioligand 125 I-BQ3020 selective for endothelin (ETB) receptors. Life Sci Pharmacol Lett 1992;51:47-52.
12. Mino N, Kobayashi M, Nakajima A, et al. Protective effect of a selective endothelin receptor antagonist. BQ-123, in ischemic acute renal failure in rats. Eur J Pharmacol 1992;221:77-83.
13. Pollock DM, Opgenorth TJ. Evidence for endothelin-induced renal vasoconstriction independent of ET-A receptor activation. Am J Physiol 1993;264:R222-6.
14. Kivlighn SD, Gabel RA, Siegl PK. Effects of BQ-123 on renal function and acute cyclosporine-induced renal dysfunction. Kidney Int 1994;45:131-6.
15. Clozel M, Breu V, Burri K, et al. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 1993;365:759-61.
16. Larivière R, Thibault G, Schiffrin EL. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension 1993;21:294-300.
17. Suzuki N, Miyauchi T, Tomobe Y, et al. Plasma concentrations of endothelin-1 in spontaneously hypertensive rats and DOCA-salt hypertensive rats. Biochem Biophys Res Commun 1989;162:38-44.
18. Cristol JP, Warner TD, Thiermermann C, Vane JR. Mediation via different receptors of the vasoconstrictor effects of endothelin and sarafotoxins in the systemic circulation and the renal vasculature of the anaesthetized rat. Br J Pharmacol 1993;108:776-9.
19. Chen PY, Sanders PW. Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats. Hypertension 1993;22: 812-8.
20. Lippton H, Goff J, Hyman A. Effects of endothelin in the systemic and renal vascular beds in vivo. Eur J Pharmacol 1988;155:197-9.
21. Wright CE, Fozard JR. Regional vasodilation is a prominent feature of the hemodynamic response to endothelin in anaesthetized spontaneously hypertensive rats. Eur J Pharmacol 1988;155: 201-3.
22. Harris PJ, Zhuo J, Menselsohn FA, Skinner SL. Haemodynamic and renal tubular effects of low doses of endothelin in anaesthetized rats. J Physiol 1991;433:25-39.
23. Badr KF, Murray JJ, Breyer MD, Takahashi K, Inagami T, Harris RC. Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. J Clin Invest 1989;83: 336-42.
24. +-ATPase in intact renal tubular epithelial cells. Am J Physiol 1989;257:C1101-7.
25. Firth JD, Ratcliffe PJ, Raine AE, Ledingham JG. Endothelin: an important factor in acute renal failure? Lancet 1988;2:1179-81.
26. Kon V, Yoshioka T, Fogo A, Ichikawa I. Glomerular actions of endothelin in vivo. J Clin Invest 1989;83:1762-7.
27. Simonson MS, Dunn MJ. Endothelin: pathways in transmembrane signalling. Hypertension 1990;15:1-5.